Béliveau, Richard <br/><br/>
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2002 
 - 1242-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Aorta--drug effects<br/>Capillaries--drug effects<br/>Capillary Permeability--drug effects<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Endothelial Growth Factors--metabolism<br/>Endothelium, Vascular--cytology<br/>Humans<br/>In Vitro Techniques<br/>Lymphokines--metabolism<br/>Phosphorylation--drug effects<br/>Protein Binding--drug effects<br/>Rats<br/>Receptor Protein-Tyrosine Kinases--metabolism<br/>Receptors, Growth Factor--metabolism<br/>Receptors, Vascular Endothelial Growth Factor<br/>Tissue Extracts--pharmacology<br/>Tyrosine--metabolism<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors